Form 4: Lucira Health, Inc. (LHDX), Prashar Tamanna, transaction 06/09/2021

Summary

A Form 4 Statement of Changes in Beneficial Ownership for Lucira Health, Inc. [LHDX], filed by Tamanna Prashar as an officer with the title Vice President, with an earliest transaction date of 06/09/2021. Table I reports acquisitions of common stock on 06/09/2021 under transaction code M: 79,484 shares at $0.82, 2,513 and 10,633 shares at $0.73, and 11,061 shares at $2.2, leaving 115,166 shares owned directly. Table II reports the matching stock options (right to buy), with expiration dates of 09/16/2029, 05/01/2030, 06/29/2030 and 09/24/2030. The footnotes state that the options are immediately exercisable and describe their vesting schedules. The form is signed /s/ Dan George, Attorney-in-Fact for Tamanna Prashar, on 02/10/2022.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * Prashar Tamanna (Last) (First) (Middle) 1412 62ND STREET (Street) EMERYVILLE CA 94608 (City) (State) (Zip) | Prashar Tamanna | (Last) | (First) | (Middle) | 1412 62ND STREET | EMERYVILLE | CA | 94608 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Lucira Health, Inc. [ LHDX ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Vice President | Director | 10% Owner | X | Officer (give title below) | Other (specify below) | Vice President
3. Date of Earliest Transaction
 (Month/Day/Year) 06/09/2021
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 06/09/2021 | M | 79,484 | A | $ 0.82 | 90,959 | D
Common Stock | 06/09/2021 | M | 2,513 | A | $ 0.73 | 93,472 | D
Common Stock | 06/09/2021 | M | 10,633 | A | $ 0.73 | 104,105 | D
Common Stock | 06/09/2021 | M | 11,061 | A | $ 2.2 | 115,166 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Stock Option (right to buy) | $ 0.82 | 06/09/2021 | M | 79,484 | (1) | 09/16/2029 | Common Stock | 79,484 | $ 0.00 | 86,397 | D
Stock Option (right to buy) | $ 0.73 | 06/09/2021 | M | 2,513 | (2) | 05/01/2030 | Common Stock | 2,513 | $ 0.00 | 6,767 | D
Stock Option (right to buy) | $ 0.73 | 06/09/2021 | M | 10,633 | (2) | 06/29/2030 | Common Stock | 10,633 | $ 0.00 | 35,767 | D
Stock Option (right to buy) | $ 2.2 | 06/09/2021 | M | 11,061 | (2) | 09/24/2030 | Common Stock | 11,061 | $ 0.00 | 156,604 | D
Explanation of Responses:
1. The shares subject to the option are immediately exercisable. Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
2. The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option shall vest monthly over the four years from the vesting commencement date.
Remarks:
/s/ Dan George, Attorney-in-Fact for Tamanna Prashar | 02/10/2022
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_LHDX_4_filed2022-02-14_0001209191-22-009441.xml

Size

21,682 bytes

SHA-256

ef6aaaac3349fedc1e3d261729bdc9e78d37cb777896c75c9b060bb722df2ea1

Our copy

SEC_LHDX_4_filed2022-02-14_0001209191-22-009441.xml

Original

www.sec.gov